John J. Lepore
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Congenital heart defects research, Cancer, Hypoxia, and Metabolism, Cardiac electrophysiology and arrhythmias, Erythropoietin and Anemia Treatment
Most-Cited Works
- → Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk(2003)414 cited
- → Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure(2006)348 cited
- → An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure(2012)328 cited
- → Cardiac hypertrophy and histone deacetylase–dependent transcriptional repression mediated by the atypical homeodomain protein Hop(2003)322 cited
- → Klf2 Is an Essential Regulator of Vascular Hemodynamic Forces In Vivo(2006)310 cited
- → Wnt/β-catenin signaling promotes expansion of Isl-1–positive cardiac progenitor cells through regulation of FGF signaling(2007)283 cited
- → A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration(2008)283 cited
- → Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction(2016)240 cited
- → Impaired Notch Signaling Promotes De novo Squamous Cell Carcinoma Formation(2006)211 cited
- → Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy(2014)201 cited